PLSE · Pulse Biosciences, Inc.
AI read · Good for PLSE
The AI's read
This moves Pulse Biosciences closer to learning whether its catheter can treat irregular heartbeats safely and effectively. Reaching the planned enrollment across 15 sites shows the study has its target group in place. Safety and effectiveness checks still come 6 and 12 months after treatment. This is a positive step, not proof that the device works.